921
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Change in calculated cardiovascular risk due to guideline revision: A cross-sectional study in the Netherlands

, , , , , , , & show all
Pages 217-223 | Received 16 Sep 2014, Accepted 31 May 2015, Published online: 31 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Edith M Heintjes, Irene D Bezemer, Daniel Prieto-Alhambra, Elisabeth Smits, Helen P Booth, Daniel Dedman, Ying He, Fabian Hoti, Minna Vehkala, Stefan de Vogel, Noah Jamie Robinson, Kwame Appenteng & Fernie J A Penning-van Beest. (2020) Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries. Clinical Epidemiology 12, pages 423-433.
Read now
Clare H Luymes, Nelleke J Boelhouwer, Rosalinde KE Poortvliet, Wouter de Ruijter, Ria Reis & Mattijs E Numans. (2017) Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patients. Patient Preference and Adherence 11, pages 975-984.
Read now

Articles from other publishers (3)

Clare Luymes, Rosalinde Poortvliet, Nan van Geloven, Margot de Waal, Yvonne Drewes, Jeanet Blom, Nynke Smidt, Willem Assendelft, Wilbert van den Hout, Wouter de Ruijter & Mattijs Numans. (2018) Staken preventieve cardiovasculaire medicatie bij laagrisicopatiënten. Huisarts en wetenschap 62:1, pages 38-41.
Crossref
Clare H. Luymes, Rosalinde K. E. Poortvliet, Nan van Geloven, Margot W. M. de Waal, Yvonne M. Drewes, Jeanet W. Blom, Nynke Smidt, Willem J. J. Assendelft, Wilbert B. van den Hout, Wouter de Ruijter & Mattijs E. Numans. (2018) Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice – the ECSTATIC study: a cluster randomised non-inferiority trial. BMC Medicine 16:1.
Crossref
Clare Luymes. (2016) Bloeddruk- en cholesterolverlagende medicatie stoppen. Huisarts en wetenschap 59:9, pages 411-411.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.